GeneNews
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
445 Apple Creek Blvd Unit 220, Markham, ...Phone Number
(855) 420-7140Revenue
<$5 MillionStock Symbol
GENIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GeneNews
GeneNews Limited is a molecular diagnostics company based in Canada and the USA, specializing in the development and commercialization of proprietary tests for early cancer detection. The company has created the Sentinel Principle platform technology, which identifies disease biomarkers from whole blood, and offers products such as ColonSentry, a blood test for colorectal cancer risk. GeneNews operates within the biotechnology and genomic biomarker industry, targeting pharmaceutical partners and healthcare providers. With a focus on personalized medicine, GeneNews is advancing the application of functional genomics to address unmet clinical needs across various health domains.Explore more
Popular SearchesGenenews LtdGenenewsGeneNews andStageZero Life Sciences Ltdgenenews CorpSIC Code 87,873NAICS Code 54,541Ticker TSX: GENShow moreGeneNews Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GeneNews your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
GeneNews, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if GeneNews had a recent Job posting/layoffs
Check if GeneNews has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when GeneNews launches new products
Check out if GeneNews is spiking on competitors!
Earning: See what the market has to say on GeneNews recently announced quarterly report
Funding: Get notified immidiatlly once GeneNews has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at GeneNews
Recommended Actions
Find VP level buyers at GeneNews
Find 2 more new buyers
Company Profile Activity
Activity Insights
GeneNews is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GeneNews is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GeneNews.
GeneNews financials insights
Gather financial insights about GeneNews, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2010
Debt
$1.4M
2011
Unspecified
$5.3M
2012
Unspecified
$6.3M
2014
Unspecified
$6M
2016
Unspecified
$371K
2017
Private Equity
$10M
2019
Share Placement
$510K
Share Placement
$3.7M
GeneNews Tech Stack
A closer look at the technologies used by GeneNews
Most Recent Scoops
Funding
Project
Funding
New Hire
Executive Move
Warren Whitehead has been named Chief Accountant. In this role, Whitehead is responsible for financial operations with the company. Previously, Whitehead served as CFO of ProMis Neuro-science Inc.
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
GeneNews News & Media
StageZero Life Sciences, DiagnoseAtHome Partner on Multicancer Blood Test | 360Dx
StageZero's Aristotle test uses mRNA technology to identify the molecular signatures of multiple cancer types.StageZero Life Sciences Ltd. (SZLSF) CEO James Howard-Tripp on Q1 2022 Results - Earnings Call Transcript
StageZero Life Sciences Ltd. (OTCPK:SZLSF) Q1 2022 Earnings Conference Call May 17, 2022 8:30 a.m.StageZero Life Sciences Launches COC Plus Worldwide
TORONTO, ON / ACCESSWIRE / May 15, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, today announced the worldwide launch of the COC Plus Program for patients currently in the COC Protocol / TREAT Program.StageZero Life Sciences Announces Warrant Extension
TORONTO, ON / ACCESSWIRE / February 4, 2022 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), a vertically integrated healthcare company devoted to improving the early detection and management of cancer and other chronic diseases through leading-edge molecular diagnostics and clinical interventions, announces that it has applied to the Toronto Stock Exchange (the "Exchange") to extend the expiry date of 5,702,314.
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GeneNews
Sign Up For FreeTo access detailed company insights
GeneNews Limited is a molecular diagnostics company based in Canada and the USA, specializing in the development and commercialization of proprietary tests for early cancer detection. The company has created the Sentinel Principle platform technology, which identifies disease biomarkers from whole blood, and offers products such as ColonSentry, a b... Read More
